Elequin Capital’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2
| Closed | -$90 | – | 546 |
|
|
2024
Q4 | $90 | Sell |
2
-163
| -99% | -$7.34K | ﹤0.01% | 467 |
|
|
2024
Q3 | $6.12K | Buy |
+165
| New | +$6.12K | ﹤0.01% | 277 |
|
|
2024
Q2 | – | Sell |
-142
| Closed | -$4.13K | – | 322 |
|
|
2024
Q1 | $4.13K | Buy |
142
+135
| +1,929% | +$3.93K | ﹤0.01% | 162 |
|
|
2023
Q4 | $193 | Sell |
7
-3
| -30% | -$83 | ﹤0.01% | 336 |
|
|
2023
Q3 | $224 | Sell |
10
-314
| -97% | -$7.03K | ﹤0.01% | 363 |
|
|
2023
Q2 | $13.2K | Buy |
+324
| New | +$13.2K | 0.01% | 272 |
|
|
2023
Q1 | – | Sell |
-16
| Closed | -$611 | – | 492 |
|
|
2022
Q4 | $611 | Buy |
+16
| New | +$611 | ﹤0.01% | 613 |
|
|
2022
Q3 | – | Sell |
-27
| Closed | -$1K | – | 653 |
|
|
2022
Q2 | $1K | Buy |
27
+6
| +29% | +$222 | ﹤0.01% | 364 |
|
|
2022
Q1 | $1K | Buy |
+21
| New | +$1K | ﹤0.01% | 300 |
|